Fresenius SE Price to Free Cash Flow Ratio 2016-2024 | FSNUY
Historical price to free cash flow ratio values for Fresenius SE (FSNUY) since 2016.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Fresenius SE Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2025-05-09 |
12.17 |
|
11.37 |
| 2024-09-30 |
9.55 |
$1.07 |
8.92 |
| 2024-06-30 |
7.47 |
$1.49 |
5.02 |
| 2024-03-31 |
6.75 |
$1.60 |
4.22 |
| 2023-12-31 |
7.75 |
$1.61 |
4.82 |
| 2023-09-30 |
7.80 |
$1.59 |
4.91 |
| 2023-06-30 |
6.92 |
$1.28 |
5.41 |
| 2023-03-31 |
6.53 |
$1.18 |
5.53 |
| 2022-12-31 |
6.77 |
$1.14 |
5.96 |
| 2022-09-30 |
5.20 |
$1.11 |
4.68 |
| 2022-06-30 |
7.30 |
$1.13 |
6.45 |
| 2022-03-31 |
8.72 |
$1.36 |
6.40 |
| 2021-12-31 |
9.47 |
$1.62 |
5.84 |
| 2021-09-30 |
11.32 |
$1.30 |
8.72 |
| 2021-06-30 |
12.27 |
$1.34 |
9.13 |
| 2021-03-31 |
10.30 |
$2.12 |
4.85 |
| 2020-12-31 |
10.68 |
$2.14 |
4.99 |
| 2020-09-30 |
10.50 |
$2.13 |
4.94 |
| 2020-06-30 |
11.20 |
$2.12 |
5.29 |
| 2020-03-31 |
8.41 |
$1.16 |
7.28 |
| 2019-12-31 |
12.73 |
$0.92 |
13.85 |
| 2019-09-30 |
10.57 |
$1.02 |
10.33 |
| 2019-06-30 |
12.27 |
$0.90 |
13.67 |
| 2019-03-31 |
12.42 |
$0.88 |
14.08 |
| 2018-12-31 |
10.77 |
$0.88 |
12.21 |
| 2018-09-30 |
16.33 |
$0.78 |
20.96 |
| 2018-06-30 |
17.85 |
$0.87 |
20.63 |
| 2018-03-31 |
16.77 |
$0.98 |
17.20 |
| 2017-12-31 |
17.17 |
$1.13 |
15.18 |
| 2017-09-30 |
17.73 |
$1.28 |
13.83 |
| 2017-06-30 |
18.81 |
$1.15 |
16.34 |
| 2017-03-31 |
17.56 |
$1.06 |
16.55 |
| 2016-12-31 |
17.08 |
$0.99 |
17.23 |
| 2016-09-30 |
17.40 |
$1.56 |
11.18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$23.628B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
